Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  Vernalis plc    VER

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
07/27/2015 07/28/2015 07/29/2015 07/30/2015 07/31/2015 Date
72.75(c) 73.5(c) 73.5(c) 75.5(c) 74.085 Last
23 310 59 684 21 397 314 558 1 436 Volume
+1.04% +1.03% 0.00% +2.72% -1.87% Change
More quotes
Financials ( GBP)
Sales 2015 18,5 M
EBIT 2015 -15,6 M
Net income 2015 -11,0 M
Finance 2015 12,7 M
Yield 2015 -
Sales 2016 -
EBIT 2016 -
Net income 2016 -
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016 -
Capi. / Sales 2015 17,4x
Capi. / Sales 2016 -
Capitalization 335 M
More Financials
Company
Vernalis Plc is a research and development stage pharmaceutical company.The company provides pharmaceutical products for a range of medical disorders.It focuses on de novo fragment and structure based drug discovery and pre clinical and clinical development.The group has one marketed product,... 
More about the company
Surperformance© ratings of Vernalis plc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERNALIS PLC
06/30 VERNALIS : Appointment of Non-Executive Director
06/30 VERNALIS : Appointment of Non-Executive Director
06/11 VERNALIS : Says Stability Testing Of 2nd Cough-Cold Product Has Begun
06/11 VERNALIS : CCP-07 starts 12 month stability testing
06/11 VERNALIS : Announces CCP-07 Starts 12 Month Stability Testing
05/06 VERNALIS : and Tris Pharma receive FDA approval of NDA for Tuzistra™ XR co..
05/06 VERNALIS : Block Listing Six Monthly Review
05/06 VERNALIS : Non-Executive Director Buys Shares (DIRECTOR DEALINGS)
More news
Sector news : Biotechnology & Medical Research - NEC
07/30 SEATTLE GENETICS : reports 2Q loss
07/30 QUINTILES TRANSNATIONAL : Announces Launch of Secondary Public Offering of Commo..
07/30 SEATTLE GENETICS : Reports Second Quarter 2015 Financial Results
More sector news : Biotechnology & Medical Research - NEC


Comments 
Advertisement
Chart VERNALIS PLC
Duration : Period :
Vernalis plc Technical Analysis Chart | VER | GB00B3Y5L754 | 4-Traders
Full-screen chart
Technical analysis trends VERNALIS PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions